The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No CSPEC related information was provided by the message!

  • See Evidence submitted by expert panel for details.

Variant: NM_000138.5(FBN1):c.6453C>T (p.Cys2151=)

CA016495

200193 (ClinVar)

Gene: FBN1
Condition: Marfan syndrome
Inheritance Mode: Autosomal dominant inheritance
UUID: a831693c-1309-4d3b-a7ac-4ac7483e8566
Approved on: 2023-09-28
Published on: 2023-09-28

HGVS expressions

NM_000138.5:c.6453C>T
NM_000138.5(FBN1):c.6453C>T (p.Cys2151=)
NC_000015.10:g.48437004G>A
CM000677.2:g.48437004G>A
NC_000015.9:g.48729201G>A
CM000677.1:g.48729201G>A
NC_000015.8:g.46516493G>A
NG_008805.2:g.213785C>T
ENST00000682170.1:n.62C>T
ENST00000316623.10:c.6453C>T
ENST00000674301.1:c.1452C>T
ENST00000316623.9:c.6453C>T
ENST00000537463.6:c.*2216C>T
ENST00000559133.5:c.1760C>T
NM_000138.4:c.6453C>T
More

Pathogenic

Met criteria codes 6
PS4 PS3 PP4 PP3 PP1_Strong PM2_Supporting

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
FBN1 VCEP
The NM_000138.5 c.6453C>T variant in FBN1does not result in an amino acid substitution. This variant was found in a proband with thoracic aortic aneurysm and/or dissection, and a systemic score of 8, which is a highly specific phenotype for Marfan syndrome (internal data-Ghent university Hospital) (PP4). This variant has been reported 6 times in ClinVar: 4 times as pathogenic, 2 times as likely pathogenic, and once as variant of uncertain significance (Variation ID: 200193). The variant has been reported in the literature in at least two unrelated individuals with a clinical diagnosis of Marfan syndrome, and in at least four unrelated individuals with clinical features of Marfan syndrome (PMID 26787436, 36517271, 21907952, 32679894, 36517271, InvitaeClinVarentry) (PS4). This variant was also found to segregate with disease in at least 5 affected relatives from multiple families (PMID 21907952, internal data) (PP1_Strong). In silico prediction programs predict that this variant may impact splicing (PP3). RNA functional studies confirmed that this variant results in the creation of a cryptic donor splice site resulting in an abnormal truncated protein (PMID 21907952, 26787436, 32123317) (PS3). This variant is not present in gnomAD (PM2_sup; https://gnomad.broadinstitute.org/ version 2.1.1). In summary, this variant meets criteria to be classified as pathogenic for Marfan syndrome based on the ACMG/AMP criteria applied, as specified by the ClinGen FBN1 VCEP: PS3, PS4, PP1_Strong, PM2_Sup, PP3, PP4
Met criteria codes
PS4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP1_Strong
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM2_Supporting
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.